Clinical Trial Update: EValuation of HumIRA® in Patients With Active Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis in EASTern European Countries

View source ↗

Summary

A completed clinical trial evaluating Humira (adalimumab) in active rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis in Eastern European co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis
• Psoriatic Arthritis
• Rheumatoid Arthritis

Drugs mentioned

• Humira (adalimumab)

Snippet

Sponsor: AbbVie (prior sponsor, Abbott) | Conditions: Ankylosing Spondylitis (AS), Psoriatic Arthritis (PsA | Status: COMPLETED | Results posted: 2013-02-07